Larvol Delta - A-Study-to-Evaluate-S241656-Alone-or-in-Combination-in-Participants-With-Selected-Myeloid-Malignancies

S241656 - Servier

Noxafil (posaconazole) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT07719348

Jul 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next